NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Astellas Promotes VP of Oncology Marketing in the Americas Region
Astellas has promoted John Demaree to VP, oncology marketing, Astellas Americas. In this role, Mr. Demaree is leading Astellas’ oncology marketing team in promotion of in-market products, preparation for new oncology product launches and strategic planning and collaboration with the company’s partner organizations in the Americas region.
He has more than 25 years of experience working in the pharmaceutical industry, with more than 20 years in oncology. Before his promotion, Mr. Demaree served as executive director, oncology marketing, where he helped execute the launch of Xtandi and promotion of Tarceva.
Sigma-Tau Pharmaceuticals Names CEO
Sigma-Tau Pharmaceuticals has appointed Michael Minarich as CEO, a role he has severed in an interim role since July 2015.
Before joining Sigma-Tau Pharmaceuticals, Mr. Minarich was providing consulting services to start-ups and early- and mid-stage companies in the biosciences and specialty pharmaceutical industries. He spent the previous 20 years as an expatriate in Asia (Seoul), Canada (Montreal) and Europe (Brussels & Prague) as the Market Company President, Czech Republic for Pharmacia Corporation and at legacy company, G.D. Searle / Monsanto, with increasing responsibilities in international general management, marketing, and business development.
Inspyr Therapeutics Appoints CEO
Inspyr Therapeutics, a clinical-stage biotechnology company developing novel prodrug therapeutics for the treatment of cancer, has named Christopher Lowe president and CEO.
Mr. Lowe brings to Inspyr Therapeutics more than 15 years of executive management experience in life sciences.
Dr. Amy Peterson
BeiGene Appoints Chief Medical Officer
BeiGene, a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, has appointed Amy Peterson, M.D., as chief medical officer, immuno-oncology.
Before joining BeiGene, Dr. Peterson was VP of clinical development at Medivation, where she was primarily responsible for the development of enzalutamide and talazoparib in breast cancer and of pidilizumab in diffuse large b-cell lymphoma.
Dr. Robert Kim
Apellis Pharmaceuticals Appoints Chief Medical Officer
Apellis Pharmaceuticals, a clinical-stage complement immunotherapy company, has expanded its executive team with the addition of Dr. Robert Kim as its Chief Medical Officer. Dr. Kim will help the company optimize its drug development strategy as its clinical programs progress toward late stage clinical testing.
Dr. Kim has more than 30 years of clinical experience in ophthalmology, most recently serving at the retina startup Vision Medicines, where he was chief medical officer and head of R&D. He is also currently associate clinical professor of ophthalmology at UCSF.
Dr. Jerome Zeldis
Sorrento Names Chief Medical Officer and President of Clinical Development
Sorrento Therapeutics, an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer, pain management, inflammation and autoimmune diseases, has named Jerome Zeldis, M.D., Ph.D., chief medical officer and president of clinical development. Dr. Zeldis joins Sorrento after a nearly 20-year career at Celgene. Most recently, Dr. Zeldis held the position of CEO of Celgene Global Health and chief medical officer of Celgene.
Celldex Appoints Chief Product Development Officer
Celldex Therapeutics has promoted Elizabeth Crowley to the newly created position of senior VP, chief product development officer. Ms. Crowley was previously senior VP of product development of Celldex and brings almost 25 years of industry experience where she was responsible for leading the execution of multiple successful drug development programs.
Razorfish Health Announces the Promotions of Three Account Leaders
Razorfish Health, an integrated health marketing agency, has promoted three members of account management team. Sarah Bast has been promoted to VP, group account director. Erica Schneider has been promoted to VP, account director. And Lisa Turzio has been promoted to senior VP, group account director.
As VP, group account director, Ms. Bast is charged with providing strategic oversight and direction for one of the agency’s largest clients. Her vast expertise in the development of multi-channel digital campaigns spans across online advertising, search engine marketing and electronic health records.
Ms. Schneider brings early mover perspective to the agency’s digital offering, along with deep experience in developing omni-channel marketing strategies.
Ms. Turzio brings a highly collaborative spirit and transformative thinking to the creation of fully integrated, multi-channel programs for health systems and their customers. She is responsible for building a team that delivers best-in-class business intelligence across professional and consumer platforms.
Dr. Barbara LePetri
The Bloc Welcomes New
Senior VP Director of Medical
& Scientific Services
The Bloc has appointed Barbara LePetri, M.D., to lead the medical strategy team as senior VP director of medical and scientific services. Dr. LePetri is charged with driving scientific strategy innovation at The Bloc, expanding the team of medical experts.
Giant Welcomes Back Chief
Giant Creative/Strategy, a full-service independent healthcare communications agency, welcomes back industry expert Eric Steckelman as chief growth officer. In this newly created role, Mr. Steckelman oversees the company’s business development, client services, and core strategic functions.
Mr. Steckelman previously was senior VP, managing director at Giant from 2012 to 2015.
HealthSTAR Communications Hires Industry Veteran as Executive VP
HealthSTAR Communications, a healthcare communications company, comprised of a fully integrated network of companies including Centron Advertising, Centron PR, Centron Market Access, HealthSTAR CES, HealthSTAR Meetings and Events, HealthSTAR Virtual and HealthSTAR Medical Education, has brought on Joe Tardibuono as executive VP. Mr. Tardibuono, who has 20-plus years of healthcare experience, joins HealthSTAR from Hudson Global.
Spectra BioPharma Selling Solutions Names President
Spectra BioPharma Selling Solutions (Spectra) has named Daryl Gaugler as president of the company. Mr. Gaugler joins Spectra’s existing management team of industry leaders and provides strategic direction and oversee the day-to-day execution of the contract sales organization formed early this year.
Dr. Peter Khoury
Nanotherapeutics Names Chief Commercial Officer
Nanotherapeutics, a contract development and manufacturing organization (CDMO), has named Peter Khoury, Ph.D., as senior VP and chief commercial officer. Before joining Nanotherapeutics, from 2014 until the present, Dr. Khoury was with the Bill & Melinda Gates Foundation, serving as senior program officer, life science partnerships, office of the president for global health. (PV)